Valiasek Kathleen

Avg. Two Year Performance

(43%) Avg. Purchase Return
(20%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(5%)(19%)(20%)(26%)(43%)
Purchase Success Rate1 of 21 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Business Officer:

Holdings: 225.01K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: 255.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--